These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 7741519)

  • 1. Poliovirus infection without accumulation of eclipse particles.
    Ofori-Anyinam O; Vrijsen R; Kronenberger P; Boeyé A
    Antiviral Res; 1995 Jan; 26(1):27-35. PubMed ID: 7741519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a capsid-stabilizing pyridazinamine, R 78206, on the eclipse and intracellular location of poliovirus.
    Ofori-Anyinam O; Vrijsen R; Kronenberger P; Boeyé A
    J Virol; 1993 Apr; 67(4):2367-9. PubMed ID: 8383247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. R75761, a lead compound for the development of antiviral drugs in late stage poliomyelitis eradication strategies and beyond.
    Thys B; De Palma AM; Neyts J; Andries K; Vrijsen R; Rombaut B
    Antiviral Res; 2008 Jun; 78(3):278-81. PubMed ID: 18294707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. H1PVAT is a novel and potent early-stage inhibitor of poliovirus replication that targets VP1.
    Tijsma A; Thibaut HJ; Spieser SA; De Palma A; Koukni M; Rhoden E; Oberste S; Pürstinger G; Volny-Luraghi A; Martin J; Marchand A; Chaltin P; Neyts J; Leyssen P
    Antiviral Res; 2014 Oct; 110():1-9. PubMed ID: 25043639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dominant drug targets suppress the emergence of antiviral resistance.
    Tanner EJ; Liu HM; Oberste MS; Pallansch M; Collett MS; Kirkegaard K
    Elife; 2014 Nov; 3():. PubMed ID: 25365453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of WIN 51711 and R 78206 as stabilizers of poliovirus virions and procapsids.
    Rombaut B; Andries K; Boeyé A
    J Gen Virol; 1991 Sep; 72 ( Pt 9)():2153-7. PubMed ID: 1716654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The antiviral compound 5-(3,4-dichlorophenyl) methylhydantoin inhibits the post-synthetic cleavages and the assembly of poliovirus in a cell-free system.
    Verlinden Y; Cuconati A; Wimmer E; Rombaut B
    Antiviral Res; 2000 Oct; 48(1):61-9. PubMed ID: 11080541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracellular proteolysis of poliovirus eclipse particles is abortive.
    Kronenberger P; Vrijsen R; Boeyé A
    J Gen Virol; 1994 Mar; 75 ( Pt 3)():573-80. PubMed ID: 8126453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 6-(3,4-Dichlorophenoxy)-3-(ethylthio)-2-pyridincarbonitrile inhibits poliovirus uncoating.
    González ME; Almela MJ; Yacout M; Carrasco L
    Antimicrob Agents Chemother; 1990 Jun; 34(6):1259-61. PubMed ID: 2168147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chloroquine induces empty capsid formation during poliovirus eclipse.
    Kronenberger P; Vrijsen R; Boeyé A
    J Virol; 1991 Dec; 65(12):7008-11. PubMed ID: 1658391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of action and capsid-stabilizing properties of VHHs with an in vitro antipolioviral activity.
    Schotte L; Strauss M; Thys B; Halewyck H; Filman DJ; Bostina M; Hogle JM; Rombaut B
    J Virol; 2014 Apr; 88(8):4403-13. PubMed ID: 24501405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective cleavage by trypsin of the capsid protein VP1 of type 3 poliovirus results in improved sorting of cell bound virions.
    Piirainen L; Airaksinen A; Hovi T; Roivainen M
    Arch Virol; 1996; 141(6):1011-20. PubMed ID: 8712919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antipoliovirus activity and mechanism of action of 3-methylthio-5-phenyl-4-isothiazolecarbonitrile.
    Garozzo A; Stivala A; Tempera G; Castro A
    Antiviral Res; 2010 Dec; 88(3):325-8. PubMed ID: 20955736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of temperature and lipophilic agents on poliovirus formation and RNA synthesis in a cell-free system.
    Molla A; Paul AV; Wimmer E
    J Virol; 1993 Oct; 67(10):5932-8. PubMed ID: 8396661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential use of antiviral agents in polio eradication.
    De Palma AM; Pürstinger G; Wimmer E; Patick AK; Andries K; Rombaut B; De Clercq E; Neyts J
    Emerg Infect Dis; 2008 Apr; 14(4):545-51. PubMed ID: 18394270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of simvastatin and methyl-beta-cyclodextrin [corrected] on inhibition of poliovirus infection.
    Liu S; Rodriguez AV; Tosteson MT
    Biochem Biophys Res Commun; 2006 Aug; 347(1):51-9. PubMed ID: 16824485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New small-molecule inhibitors effectively blocking picornavirus replication.
    Ford Siltz LA; Viktorova EG; Zhang B; Kouiavskaia D; Dragunsky E; Chumakov K; Isaacs L; Belov GA
    J Virol; 2014 Oct; 88(19):11091-107. PubMed ID: 25008939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heat stabilized, infectious poliovirus.
    Ofori-Anyinam O; Vrijsen R; Kronenberger P; Boeyé A
    Vaccine; 1995 Aug; 13(11):983-6. PubMed ID: 8525692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of poliovirus uncoating by disoxaril (WIN 51711).
    Zeichhardt H; Otto MJ; McKinlay MA; Willingmann P; Habermehl KO
    Virology; 1987 Sep; 160(1):281-5. PubMed ID: 2820136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of arildone and 3-methylquercetin as stabilizers of poliovirus.
    Rombaut B; Vrijsen R; Boeye A
    Antiviral Res; 1985; Suppl 1():67-73. PubMed ID: 3002268
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.